4-2833015-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001122681.2(SH3BP2):​c.1514C>G​(p.Ser505Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000542 in 1,614,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S505F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

SH3BP2
NM_001122681.2 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.934

Publications

4 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006813228).
BP6
Variant 4-2833015-C-G is Benign according to our data. Variant chr4-2833015-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 348593.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00275 (419/152374) while in subpopulation AFR AF = 0.0088 (366/41584). AF 95% confidence interval is 0.00806. There are 0 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 419 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001122681.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SH3BP2
NM_001122681.2
MANE Select
c.1514C>Gp.Ser505Cys
missense
Exon 12 of 13NP_001116153.1A0A384N6E5
SH3BP2
NM_001145856.2
c.1685C>Gp.Ser562Cys
missense
Exon 12 of 13NP_001139328.1P78314-4
SH3BP2
NM_001145855.2
c.1598C>Gp.Ser533Cys
missense
Exon 12 of 13NP_001139327.1P78314-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SH3BP2
ENST00000503393.8
TSL:1 MANE Select
c.1514C>Gp.Ser505Cys
missense
Exon 12 of 13ENSP00000422168.3P78314-1
SH3BP2
ENST00000511747.6
TSL:1
c.1685C>Gp.Ser562Cys
missense
Exon 12 of 13ENSP00000424846.2P78314-4
SH3BP2
ENST00000356331.10
TSL:1
n.1775C>G
non_coding_transcript_exon
Exon 12 of 13

Frequencies

GnomAD3 genomes
AF:
0.00275
AC:
419
AN:
152256
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00883
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000668
AC:
168
AN:
251438
AF XY:
0.000508
show subpopulations
Gnomad AFR exome
AF:
0.00757
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000312
AC:
456
AN:
1461876
Hom.:
0
Cov.:
31
AF XY:
0.000264
AC XY:
192
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00983
AC:
329
AN:
33480
American (AMR)
AF:
0.000961
AC:
43
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1112000
Other (OTH)
AF:
0.000878
AC:
53
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00275
AC:
419
AN:
152374
Hom.:
0
Cov.:
32
AF XY:
0.00247
AC XY:
184
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00880
AC:
366
AN:
41584
American (AMR)
AF:
0.00274
AC:
42
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68034
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000148
Hom.:
0
Bravo
AF:
0.00306
ESP6500AA
AF:
0.00862
AC:
38
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000667
AC:
81
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Fibrous dysplasia of jaw (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.0068
T
MetaSVM
Benign
-0.50
T
PhyloP100
0.93
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.31
Sift
Benign
0.050
D
Sift4G
Benign
0.13
T
Polyphen
0.69
P
Vest4
0.21
MVP
0.89
MPC
0.16
ClinPred
0.015
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.052
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144577122; hg19: chr4-2834742; API